Default company panoramic image

Signum Nutralogix, Inc.

A Princeton Univ. spinout; we developed Cognion™, a dietary supplement that enhances brain health. We are raising funds for product launch.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Princeton, NJ, USA
  • Currency USD
  • Founded January 2012
  • Employees 4
  • Website

Company Summary

Our Mission is to create a business of scale by commercializing Cognion, a patented brain health dietary supplement, as a unique nutraceutical targeting cognitive health. Signum Nutralogix, a private biotechnology company, is focused on the development and commercialization of innovative dietary supplements to enhance health in an ageing population. Nutralogix was founded in 2012 to exploit scientific breakthroughs made at Princeton University.


  • Default avatar
    Maxwell Stock

    A serial entrepreneur in the health care space specializing in the neuroscience and dermatology fields. He is the CEO & co-founder of Signum Biosciences and Signum Dermalogix, Inc. An inventor on Signum’s patents, he has also negotiated and lead long term partnerships and alliances with major multinationals as well as out licensed multiple technologies to big pharma and global consumer product companies.